Results 241 to 250 of about 85,963 (263)

Understanding JAK inhibitor toxicity

Journal of the American Academy of Dermatology
Athira, Sivadas, Kevin W, Byram, Manuel, Valdebran, Tyler, Beck   +3 more
openaire   +2 more sources

MACROCYCLIC INHIBITORS OF JAK

2011
JAHANGIR ALAM, LYNCH STEPHEN M, SOTH MICHAEL, YANG HANBIAO   +3 more
openaire   +3 more sources

SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS

2022
JACOBSEN ERIC JON, ANDERSON DAVID RANDOLPH, BLINN JAMES ROBERT, MUKHERJEE PARAMITA, CHANGELIAN PAUL, XU CANXIN   +5 more
openaire   +2 more sources

A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia, 2015
Farhad Ravandi
exaly  

DIHYDROPYRROLONAPHTHYRIDINONE COMPOUNDS AS INHIBITORS OF JAK

2010
DONG QING, KANOUNI TOUFIKE, LAWSON JOHN DAVID, WALLACE MICHAEL B   +3 more
openaire   +5 more sources

JAK INHIBITORS

2019
openaire   +3 more sources

The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppressive Agent in Various Murine Models

American Journal of Transplantation, 2004
exaly  

JAK INHIBITOR

2008
AMISHIRO NOBUYOSHI, ATSUMI TOSHIYUKI, NAKAZATO TOMOYUKI, UMEHARA HIROSHI, FUJIHARA HIROAKI, SHINOHARA FUMIKAZU, FUNAHASHI JUN, YAMAMOTO JUNICHIRO, YAGI KAORI   +8 more
openaire   +1 more source

Combination of JAK inhibitor and immune checkpoint inhibitor in clinical trials: a breakthrough

Frontiers in Immunology
Zhongnan Ma
exaly  

Inhibitors of JAK

2013
DE VICENTE FIDALGO JAVIER, HERMANN JOHANNES CORNELIUS, LEMOINE REMY, LI HONGJU, LOVEY ALLEN JOHN, SJOGREN ERIC BRIAN, SOTH MICHAEL   +6 more
openaire   +1 more source